Postdoctoral Research Associate
Posted 8 days 22 hours ago by Barts Cancer Institute , Queen Mary University London
Permanent
Part Time
Academic Jobs
London, United Kingdom
Job Description
About the Role
We are seeking to recruit an outstanding lab-based molecular biologist with or about to receive a PhD, who has experience in development and application of next-generation sequencing assays, to play a key role in development and deployment of cutting-edge methods to detect cancer earlier than traditional methods.
About You
Experience of translational research using human samples, the development of clinical diagnostic assays, and bioinformatic analysis of next generation sequencing data would be a distinct advantage. You will be a highly motivated, detail-oriented individual with excellent communication skills and who is well organised. You will be able to work independently and interact effectively in a multi-disciplinary team environment.
About the Institute / About the Project
The Rosenfeld lab () at the Barts Cancer Institute, Queen Mary University of London, pioneers new approaches for minimally-invasive molecular diagnostics and analysis of cancer genomes, using next-generation sequencing of circulating cell-free tumour DNA (ctDNA). The group is a dynamic mix of molecular biologists, bioinformaticians and clinical fellows providing a unique environment for development and learning in cancer genomics and translational research. We work with large collections of patient samples from different clinical studies, which we analyse by both genome-wide and targeted methods for sensitive mutation detection. We aim to develop novel tools for cancer diagnostics by developing improved methods and demonstrating clinical utility. Furthermore, we explore the biophysical properties of ctDNA with the aim of identifying its origins and interactions.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we've fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it's simply 'the right thing to do' but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days' leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary's commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
We are seeking to recruit an outstanding lab-based molecular biologist with or about to receive a PhD, who has experience in development and application of next-generation sequencing assays, to play a key role in development and deployment of cutting-edge methods to detect cancer earlier than traditional methods.
About You
Experience of translational research using human samples, the development of clinical diagnostic assays, and bioinformatic analysis of next generation sequencing data would be a distinct advantage. You will be a highly motivated, detail-oriented individual with excellent communication skills and who is well organised. You will be able to work independently and interact effectively in a multi-disciplinary team environment.
About the Institute / About the Project
The Rosenfeld lab () at the Barts Cancer Institute, Queen Mary University of London, pioneers new approaches for minimally-invasive molecular diagnostics and analysis of cancer genomes, using next-generation sequencing of circulating cell-free tumour DNA (ctDNA). The group is a dynamic mix of molecular biologists, bioinformaticians and clinical fellows providing a unique environment for development and learning in cancer genomics and translational research. We work with large collections of patient samples from different clinical studies, which we analyse by both genome-wide and targeted methods for sensitive mutation detection. We aim to develop novel tools for cancer diagnostics by developing improved methods and demonstrating clinical utility. Furthermore, we explore the biophysical properties of ctDNA with the aim of identifying its origins and interactions.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we've fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it's simply 'the right thing to do' but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days' leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary's commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.